Epigenic Therapeutics

Epigenic Therapeutics develops biotechnology solutions for gene modulation therapies. The Company advances proprietary technology platforms and conducts drug discovery and clinical development for chronic, metabolic, cardiovascular, viral hepatitis, ocular, neurodegenerative, and rare diseases. Epigenic Therapeutics serves patients in the United States, Japan, and China.